STAT4 is required for IFN-β-induced MCP-1 mRNA expression in murine mast cells

International Archives of Allergy and Immunology

Volumn 155, Issue SUPPL. 1, 2011, Pages 71-76

  Iida, Kazuma ^a   Suzuki, Kotaro ^a   Yokota, Masaya ^a   Nakagomi, Daiki ^a   Wakashin, Hidefumi ^a   Iwata, Arifumi ^a   Kawashima, Hirotoshi ^a   Takatori, Hiroaki ^a   Nakajima, Hiroshi ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

IFN ; Mast cells; MCP 1; STAT4

Indexed keywords

IMMUNOGLOBULIN E; INTERFERON INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEAT 1; INTERLEUKIN 23; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MYXOVIRUS RESISTANCE 1 PROTEIN; MYXOVIRUS RESISTANCE PROTEIN; PROTEIN; PROTEIN KINASE INTERFERON-INDUCIBLE DOUBLE STRANDED RNA DEPENDENT; RECOMBINANT BETA INTERFERON; RECOMBINANT INTERLEUKIN 12; STAT4 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; BONE MARROW CELL; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE RESPONSE; DEGRANULATION; GENE ACTIVATION; GENE EXPRESSION; INNATE IMMUNITY; MAST CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE; TETRATRICOPEPTIDE REPEAT; WILD TYPE;

ANIMALS; BETA-N-ACETYLHEXOSAMINIDASES; CELL DEGRANULATION; CELL PROLIFERATION; CHEMOKINE CCL2; GENE EXPRESSION; GENE EXPRESSION REGULATION; INTERFERON-BETA; INTERLEUKIN-3; MAST CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTORS, IGE; STAT1 TRANSCRIPTION FACTOR; STAT4 TRANSCRIPTION FACTOR;

EID: 79958132552     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000327300     Document Type: Conference Paper

References (27)

1. Galli SJ, Hammel I: Mast cell and basophil development. Curr Opin Hematol 1994;1:33-39.
2. Metcalfe DD, Baram D, Mekori YA: Mast cells. Physiol Rev 1997;77:1033-1079. (Pubitemid 27459579)
3. Echtenacher B, Mannel DN, Hultner L: Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996;381:75-77. (Pubitemid 26130005)
4. Malaviya R, Ikeda T, Ross E, Abraham SN: Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature 1996;381:77-80. (Pubitemid 26130006)
5. Malaviya R, Gao Z, Thankavel K, Merwe PA, Abraham SN: The mast cell tumor necrosis factor α response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48. Proc Natl Acad Sci USA 1999;96:8110-8115.
6. McCurdy JD, Lin TJ, Marshall JS: Toll-like receptor 4-mediated activation of murine mast cells. J Leukoc Biol 2001;70:977-984. (Pubitemid 33151136)
7. Pestka S, Langer JA, Zoon KC, Samuel CE: Interferons and their actions. Annu Rev Biochem 1987;56:727-777. (Pubitemid 17105465)
8. Leonard WJ, O'Shea JJ: JAKs and STATs: biological implications. Annu Rev Immunol 1998;16:293-322. (Pubitemid 28183367)
9. Darnell JE Jr, Kerr IM, Stark GR: JAK-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994;264:1415-1421. (Pubitemid 24217131)
10. Ihle JN, Nosaka T, Thierfelder W, Quelle FW, Shimoda K: JAKs and STATs in cytokine signaling. Stem Cells 1997;15:105-111.
11. Ikeda K, Nakajima H, Suzuki K, Watanabe N, Kagami SI, Iwamoto I: STAT5a is essential for the proliferation and survival of murine mast cells. Int Arch Allergy Immunol 2005; 137:s45-s50.
12. Suzuki K, Nakajima H, Kagami SI, Suto A, Ikeda K, Hirose K, Hiwasa T, Takeda K, Saito Y, Akira S, Iwamoto I: Proteolytic processing of STAT6 signaling in mast cells as a negative regulatory mechanism. J Exp Med 2002;196: 27-38. (Pubitemid 34747309)
13. Suzuki K, Nakajima H, Ikeda K, Maezawa Y, Suto A, Takatori H, Saito Y, Iwamoto I: IL-4-STAT6 signaling induces tristetraprolin expression and inhibits TNF-α production in mast cells. J Exp Med 2003;198:1717-1727. (Pubitemid 37494164)
14. Kaplan MH, Sum YL, Hoey T, Grusby MJ: Impaired IL-12 responses and enhanced development of Th2 cells in STAT4-deficient mice. Nature 1996;382:174-177. (Pubitemid 26242885)
15. Suzuki K, Nakajima H, Watanabe N, Kagami S, Suto A, Saito Y, Saito T, Iwamoto I: Role of common cytokine receptor γ chain (γ c)- and Jak3-dependent signaling in the proliferation and survival of murine mast cells. Blood 2000;96:2172-2180.
16. Watford WT, Hissong BD, Bream JH, Kanno Y, Muul L, O'Shea JJ: Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol Rev 2004;202:139-156. (Pubitemid 39576910)
17. Berenson LS, Gavrieli M, Farrar JD, Murphy TL, Murphy KM: Distinct characteristics of murine STAT4 activation in response to IL-12 and IFN-α. J Immunol 2006;177:5195-5203. (Pubitemid 44527592)
18. Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M: Mast cells as 'tunable' effector and immunoregulatory cells: recent advances. Annu Rev Immunol 2005;23:749-786.
19. Galli SJ, Nakase S, Tsai M: Mast cells in the development of adaptive immune responses. Nat Immunol 2005;6:135-142. (Pubitemid 40268194)
20. Sadler AJ, Williams BR: Interferon-inducible antiviral effectors. Nat Rev Immunol 2008;8: 559-568. (Pubitemid 351913674)
21. Randall RE, Goodbourn S: Interferons and viruses: an interplay between induction, signaling, antiviral responses and virus countermeasures. J Gen Virol 2008;89:1-47.
22. O'Shea JJ, Murray PJ: Cytokine signaling modules in inflammatory responses. Immunity 2008;28:477-487. (Pubitemid 351467044)
23. Desshmane SL, Kremlev S, Amini S, Sawaya BE: Monocyte chemoattractant protein 1 (MCP-1): an overview. J Interferon Cytokine Res 2009;29:313-326.
24. Li H, Gade P, Xiao W, Kalvakolanu DV: The interferon signaling network and transcription factor C/EBP-β. Cell Mol Immunol 2007;4:407-418.
25. Wesoly J, Szweykowska-Kulinska Z, Bluyssen HA: STAT activation and differential complex formation dictate selectivity of interferon responses. Acta Biochim Pol 2007; 54:27-38. (Pubitemid 46481813)
26. Fitzgerland-Bocarsly P, Dai J, Singh S:Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history. Cytokine Growth Factor Rev 2008;19:3-19.
27. Hokeness KL, Kuziel WA, Biron CA, Salazar-Mather TP: Monocyte chemoattractant protein-1 and CCR2 interactions are required for IFNα/β-induced inflammatory responses and antiviral defense in liver. J Immunol 2005;174:1549-1556.